Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Jon Lawson

Physician Assistant Fresh Meadows, NY Physician Assistant

NPI 1124452396 CMS profile 10887972

7373 197Th St, 2Nd Floor, Fresh Meadows, NY 11366

Open in the dashboard

General payments

$4,416

95 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jon Lawson of Fresh Meadows, NY is reported in the CMS Open Payments database as having received $4,416 across 95 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $526 5
2024 General $1,699 15
2023 General $513 12
2022 General $757 17
2021 General $919 46

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jon Lawson
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Jon Lawson were reported at $526. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Jon Lawson Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $919 $132 $37–$438 $132
2022 $757 $155 $48–$522 $149
2023 $513 $167 $52–$557 $160
2024 $1,699 $178 $55–$600 $164
2025 $526 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Abbott Laboratories $2,725 43 payments
  2. Medtronic, Inc. $921 27 payments
  3. Edwards Lifesciences Corporation $534 16 payments
  4. Boston Scientific Corporation $139 8 payments
  5. Abiomed $98 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $3,474 89 payments
  2. Travel and Lodging $942 6 payments
Products named General payments · program years 2021–2025
  1. CARDIOMEMS Heart failure $1,361 12 payments
  2. COREVALVE EVOLUT R $566 10 payments
  3. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $519 15 payments
  4. CARDIOMEMS Structural Heart $437 4 payments
  5. NAVITOR $294 5 payments
  6. CoreValve Evolut $266 16 payments
  7. MITRACLIP $222 3 payments
  8. Impella $98 1 payment
  9. SYMPLICITY G3 $89 1 payment
  10. MitraClip System $77 4 payments
  11. Other $486 24 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 12 drugs

Part D claims

428

Median for Physician Assistant: 241

Drug cost

$439,626

Median for Physician Assistant: $4,110

Branded share of claims

43.2%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Vyndamax Tafamidis Brand 13 $286,572
Entresto Sacubitril/Valsartan Brand 65 $55,869
Farxiga Dapagliflozin Propanediol Brand 46 $43,564
Eliquis Apixaban Brand 27 $26,196
Jardiance Empagliflozin Brand 34 $24,716
Metoprolol Succinate Generic 68 $1,283
Bumetanide Generic 21 $657
Spironolactone Generic 69 $376
Furosemide Generic 35 $130
Losartan Potassium Generic 20 $109

The 10 drugs with the highest cost, of 12 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 14 billing codes

Paid by Medicare

$16,169

Medicare's payments for the services billed

Medicare patients

77

Average age 81

Services billed

380

35 women, 42 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 75%
Ischemic heart disease 75%
Chronic kidney disease 71%
Arthritis 71%
Atrial fibrillation 69%
Diabetes 61%
COPD 52%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

95 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record